CAH - Educational Analysis * US Equities
Educational Analysis * US Equities

CAH

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerCAH
CategoryEducational primer
Last reviewedJuly 27, 2026
You're viewing an older edition of this page.Read the latest edition →

CAH Earnings Track Record: Why a Perfect Beat Rate Has Not Meant a Straight Line Up

Cardinal Health (CAH) enters its August 11, 2026 earnings report with a flawless recent record: over the last eight reported quarters, CAH has beaten the consensus estimate all eight times, a 100% beat rate, and the average earnings surprise has been 10.8%. That number alone points to persistent outperformance relative to analyst models. What makes the setup educational is what happened next. Across those same quarters, the average five-day price move in the trading sessions after earnings was -0.78%, classified as a down drift. The headline beat and the post-event price path have repeatedly diverged.

The most recent reports illustrate the pattern in dollar-and-cents terms. On April 30, 2026, CAH reported actual EPS of $3.17 versus an estimate of $2.79, a 13.6% surprise, yet the stock gained 1.22% the next day and then slid 3.94% over the following five trading days. The February 5, 2026 quarter was similar: actual EPS of $2.63 against an estimate of $2.34, a 12.4% surprise, with the stock falling 0.38% the next day and 5.33% over the next five sessions. Only the October 30, 2025 report bucked the down-drift label: a 17% surprise on EPS of $2.55 versus $2.18 produced a 0.49% next-day gain and a 4.29% five-day gain. The August 12, 2025 quarter, a 2% beat with actual EPS of $2.08 versus $2.04, added 1.24% the next day and 1.86% over the following week. The takeaway is that even when CAH beats, the post-earnings continuation has been inconsistent.

Options-Flow Dynamics Around the August 11 Earnings Date

The next scheduled report is August 11, 2026, before market open, with a consensus EPS estimate of $2.42. Because CAH has beaten in 100% of the last eight quarters, options positioning can become a study in how the market prices a "beat" versus how it prices the subsequent price path. Implied volatility typically rises into the event and collapses after the number, but the more interesting question is whether the options market is pricing a one-day gap or a multi-day swing. If the flow is concentrated in short-dated calls, it may reflect positioning for an immediate reaction; if put spreads or longer-dated straddles are active, it can reflect expectations that any gap could reverse.

The current snapshot adds context: CAH is trading at $228.03, with an RSI of 51.7 and the 50-day EMA at $222.06, in the Healthcare/Medical - Distribution sector. Those levels give traders reference points to compare against any post-earnings move. Options flow around the event should be read alongside that technical backdrop, not in isolation. A strong beat on August 11 that still gaps below the 50-day EMA would tell a different story than a beat that holds above it.

What a Disciplined Trader Watches Given CAH's Historical Pattern

A disciplined trader treats CAH's 100% beat rate and 10.8% average surprise as historical facts, not a reason to assume direction. The evidence shows that beats have been followed by both one-day gains and five-day declines. The first thing to watch is the immediate reaction relative to the unofficial consensus. A beat larger than the 10.8% average has sometimes produced one-day strength, but the five-day drift has still been negative on average.

The second thing to watch is whether the stock gaps and then fades. The February 5, 2026 and April 30, 2026 quarters both showed this behavior. The third thing to watch is implied volatility. If options premium was expensive into the report, a beat that does not produce a large move can trigger volatility compression that works against long options positions regardless of direction. Finally, traders can use the 50-day EMA at $222.06 as a structural level to frame risk, with the understanding that a beat does not automatically place the stock above that average.

For a deeper dive into how institutional analysts, hedge funds, and options desks are positioning around CAH ahead of the August 11 report, see the full institutional verdict on the ticker page. It aggregates the buy-side and sell-side consensus, flow trends, and technical setup beyond the earnings history covered here.

Frequently Asked Questions

How often has CAH beaten earnings estimates?

Over the last eight reported quarters, CAH beat the consensus earnings estimate all eight times, a 100% beat rate, with an average earnings surprise of 10.8%.

What happened to CAH stock after its most recent earnings report?

On April 30, 2026, CAH reported actual EPS of $3.17 versus an estimate of $2.79, a 13.6% surprise. The stock rose 1.22% the next day, then fell 3.94% over the following five trading days, continuing the pattern in which beats do not reliably produce sustained post-earnings upside.

When is CAH's next earnings report and what is the consensus estimate?

CAH's next scheduled earnings report is August 11, 2026, before market open, with a consensus EPS estimate of $2.42.

Real Data - Gamma QC Earnings IntelligenceAs of Jul 27, 2026
100%Beat rate, last 8Q
10.8%Avg EPS surprise
-0.78%Avg 5-day move after earnings
2026-08-11Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-04-30$3.17$2.79+13.6%+1.22%-3.94%
2026-02-05$2.63$2.34+12.4%-0.38%-5.33%
2025-10-30$2.55$2.18+17%+0.49%+4.29%
2025-08-12$2.08$2.04+2%+1.24%+1.86%
2025-05-01$2.35$2.17+8.3%--
2025-01-30$1.93$1.74+10.9%--

Previous CAH editions

Beyond the primer

Get the institutional verdict on CAH

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the CAH verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.